961.11(6)(a)(a) The controlled substances board shall not have authority to control a nonnarcotic substance if the substance may, under the federal food, drug and cosmetic act and the laws of this state, be lawfully sold over the counter without a prescription.
961.11(6)(b) (b) If the board finds that any nonnarcotic substance barred from control under this chapter by par. (a) is dangerous to or is being so used as to endanger the public health and welfare, it may request the department of justice in the name of the state to seek a temporary restraining order or temporary injunction under ch. 813 to either ban or regulate the sale and possession of the substance. The order or injunction shall continue until the adjournment of the legislature convened next following its issuance. In making its findings as to nonnarcotic substances under this paragraph, the board shall consider the items specified in sub. (1m).
961.11 History History: 1971 c. 219, 307; Sup. Ct. Order, 67 W (2d) 585, 774 (1975); 1981 c. 79 s. 18; 1983 a. 189 s. 329 (13); 1995 a. 448 ss. 145 to 152, 469, 470; Stats. 1995 s. 961.11.
961.115 961.115 Native American Church exemption. This chapter does not apply to the nondrug use of peyote and mescaline in the bona fide religious ceremonies of the Native American Church.
961.115 History History: 1971 c. 219; 1995 a. 448 s. 153; Stats. 1995 s. 961.115.
961.115 Annotation Because exemption is based upon unique cultural heritage of Native Americans, it is not unconstitutional classification. State v. Peck, 143 W (2d) 624, 422 NW (2d) 160 (Ct. App. 1988).
961.12 961.12 Nomenclature. The controlled substances listed in or added to the schedules in ss. 961.14, 961.16, 961.18, 961.20 and 961.22 may be listed or added by any official, common, usual, chemical or trade name used for the substance.
961.12 History History: 1971 c. 219; 1995 a. 448 s. 154; Stats. 1995 s. 961.12.
961.13 961.13 Schedule I tests.
961.13(1m)(1m) The controlled substances board shall add a substance to schedule I upon finding that the substance:
961.13(1m)(a) (a) Has high potential for abuse;
961.13(1m)(b) (b) Has no currently accepted medical use in treatment in the United States; and
961.13(1m)(c) (c) Lacks accepted safety for use in treatment under medical supervision.
961.13(2m) (2m) The controlled substances board may add a substance to schedule I without making the findings required under sub. (1m) if the substance is controlled under schedule I of 21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.13 History History: 1971 c. 219; 1995 a. 448 ss. 155, 156, 471; Stats. 1995 s. 961.13.
961.14 961.14 Schedule I. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I:
961.14(2) (2)Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
961.14(2)(a) (a) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- phenylethyl)-4-piperidinyl]-N-phenylacetamide);
961.14(2)(ag) (ag) Acetylmethadol;
961.14(2)(am) (am) Allylprodine;
961.14(2)(b) (b) Alphacetylmethadol (except levo-alphacetylmethadol (LAAM));
961.14(2)(bm) (bm) Alphameprodine;
961.14(2)(c) (c) Alphamethadol;
961.14(2)(cd) (cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(cg) (cg) Alpha-methylthiofentanyl (N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(cm) (cm) Benzethidine;
961.14(2)(d) (d) Betacetylmethadol;
961.14(2)(dg) (dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(dm) (dm) Betameprodine;
961.14(2)(e) (e) Betamethadol;
961.14(2)(em) (em) Betaprodine;
961.14(2)(er) (er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy- 2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(f) (f) Clonitazene;
961.14(2)(fm) (fm) Dextromoramide;
961.14(2)(gm) (gm) Diampromide;
961.14(2)(h) (h) Diethylthiambutene;
961.14(2)(hg) (hg) Difenoxin;
961.14(2)(hm) (hm) Dimenoxadol;
961.14(2)(j) (j) Dimepheptanol;
961.14(2)(jm) (jm) Dimethylthiambutene;
961.14(2)(k) (k) Dioxaphetyl butyrate;
961.14(2)(km) (km) Dipipanone;
961.14(2)(m) (m) Ethylmethylthiambutene;
961.14(2)(mm) (mm) Etonitazene;
961.14(2)(n) (n) Etoxeridine;
961.14(2)(nm) (nm) Furethidine;
961.14(2)(p) (p) Hydroxypethidine;
961.14(2)(pm) (pm) Ketobemidone;
961.14(2)(q) (q) Levomoramide;
961.14(2)(qm) (qm) Levophenacylmorphan;
961.14(2)(qs) (qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- piperidinyl]-N-phenylpropanamide);
961.14(2)(r) (r) Morpheridine;
961.14(2)(rg) (rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
961.14(2)(rj) (rj) 3-methylthiofentanyl (N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(rm) (rm) Noracymethadol;
961.14(2)(s) (s) Norlevorphanol;
961.14(2)(sm) (sm) Normethadone;
961.14(2)(t) (t) Norpipanone;
961.14(2)(tg) (tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
961.14(2)(tm) (tm) Phenadoxone;
961.14(2)(u) (u) Phenampromide;
961.14(2)(um) (um) Phenomorphan;
961.14(2)(v) (v) Phenoperidine;
961.14(2)(vg) (vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
961.14(2)(vm) (vm) Piritramide;
961.14(2)(w) (w) Proheptazine;
961.14(2)(wm) (wm) Properidine;
961.14(2)(wn) (wn) Propiram;
961.14(2)(x) (x) Racemoramide;
961.14(2)(xm) (xm) Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(xr) (xr) Tilidine;
961.14(2)(y) (y) Trimeperidine.
961.14(3) (3)Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(3)(a) (a) Acetorphine;
961.14(3)(b) (b) Acetyldihydrocodeine;
961.14(3)(c) (c) Benzylmorphine;
961.14(3)(d) (d) Codeine methylbromide;
961.14(3)(e) (e) Codeine-N-oxide;
961.14(3)(f) (f) Cyprenorphine;
961.14(3)(g) (g) Desomorphine;
961.14(3)(h) (h) Dihydromorphine;
961.14(3)(hm) (hm) Drotebanol;
961.14(3)(j) (j) Etorphine, except its hydrochloride salts;
961.14(3)(k) (k) Heroin;
961.14(3)(m) (m) Hydromorphinol;
961.14(3)(n) (n) Methyldesorphine;
961.14(3)(p) (p) Methyldihydromorphine;
961.14(3)(q) (q) Morphine methylbromide;
961.14(3)(r) (r) Morphine methylsulfonate;
Loading...
Loading...
This is an archival version of the Wis. Stats. database for 1997. See Are the Statutes on this Website Official?